Search Results
Department of Nuclear Medicine, The Fourth hospital of Hebei Medical University, Shijiazhuang, Hebei, China
Search for other papers by Zhaoqi Zhang in
Google Scholar
PubMed
Search for other papers by Josef Yu in
Google Scholar
PubMed
Search for other papers by Eva Rainer in
Google Scholar
PubMed
Search for other papers by Lindsay Hargitai in
Google Scholar
PubMed
Search for other papers by Zewen Jiang in
Google Scholar
PubMed
Search for other papers by Georgios Karanikas in
Google Scholar
PubMed
Search for other papers by Tatjana Traub-Weidinger in
Google Scholar
PubMed
Search for other papers by Richard Crevenna in
Google Scholar
PubMed
Search for other papers by Marcus Hacker in
Google Scholar
PubMed
Search for other papers by Shuren Li in
Google Scholar
PubMed
, early diagnosis of the primary tumor and metastases is essential for outcomes. Basal calcitonin (bCt) and carcinoembryonic antigen (CEA) can be used for diagnosis and follow-up of MTC. In case of increased bCt levels, a calcium stimulation test may be